High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways
Science Advances · 03.01.2025 · 11 (1)
DOI: 10.1126/sciadv.adq8229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 03.01.2025. Verfasst von Joshua M Peters und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, MIT, Cambridge, MA, USA. Hauptthemen laut MEDLINE: BCG Vaccine, Macaca mulatta, Signal Transduction, Vaccination. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Intradermal Bacillus Calmette-Guérin (BCG) is the most widely administered vaccine, but it does not sufficiently protect adults against pulmonary tuberculosis. Recent studies in nonhuman primates show that intravenous BCG administration offers superior protection against Mycobacterium tuberculosis ( Mtb ). We used single-cell analysis of bronchoalveolar lavage cells from rhesus macaques vaccinated via different routes and doses of BCG to identify alterations in the immune ecosystem in the airway following vaccination. Our findings reveal that high-dose intravenous BCG induces an influx of polyfunctional T cells and macrophages in the airways, with alveolar macrophages from high-dose intravenous BCG displaying a basal activation state in the absence of purified protein derivative stimulation, defined in part by interferon signaling. Enhanced intercellular immune signaling and stronger T helper 1–T helper 17 transcriptional responses were observed following purified protein derivative stimulation. These results suggest that high-dose intravenous BCG vaccination creates a specialized immune environment that primes airway cells for effective Mtb clearance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Engineering, MIT, Cambridge, MA, USA.
- Ragon Institute of MGH, Harvard, and MIT, Cambridge, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
- Division of Infectious Diseases, MGH, Boston, MA, USA.
ORCID-Profile: Joshua M Peters, Marc H Wadsworth, Matthew S Sutton, Sarah K Nyquist, Joshua D Bromley, Rajib Mondal, Mario Roederer, Robert A Seder, Patricia A Darrah, Galit Alter, JoAnne L Flynn, Alex K Shalek, Sarah M Fortune, Bryan D Bryson
Förderung
- NCATS NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Peters, J. M., Irvine, E. B., Makatsa, M. S., Rosenberg, J. M., Wadsworth, M. H., Hughes, T. K., Sutton, M. S., Nyquist, S. K., Bromley, J. D., Mondal, R., Roederer, M., Seder, R. A., Darrah, P. A., Alter, G., Seshadri, C., Flynn, J. L., Shalek, A. K., Fortune, S. M., & Bryson, B. D. (2025). High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways. Science Advances, 11(1). https://doi.org/10.1126/sciadv.adq8229
Vancouver
Peters JM, Irvine EB, Makatsa MS, Rosenberg JM, Wadsworth MH, Hughes TK, et al. High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways. Science Advances. 2025;11(1). doi:10.1126/sciadv.adq8229
BibTeX
@article{Peters2025,
author = {Peters, Joshua M and Irvine, Edward B and Makatsa, Mohau S and Rosenberg, Jacob M and Wadsworth, Marc H and Hughes, Travis K and Sutton, Matthew S and Nyquist, Sarah K and Bromley, Joshua D and Mondal, Rajib and Roederer, Mario and Seder, Robert A and Darrah, Patricia A and Alter, Galit and Seshadri, Chetan and Flynn, JoAnne L and Shalek, Alex K and Fortune, Sarah M and Bryson, Bryan D},
title = {High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {1},
doi = {10.1126/sciadv.adq8229}
}
EUVIMED